Research Trial articles, blogs, webinars, videos, fact sheets, resources, etc.
Unlocking Cancer Interception
Since our founding in 2012, Basser has been steadfast in our commitment to BRCA mutation carriers and their families. Now we are doubling down with the creation of the Basser Cancer Interception Institute, which aims to dramatically disrupt the timeline of cancer treatment, intercepting disease when the very first abnormal BRCA1/2 cells develop.
WSJ: Researchers At Health Institutions Like Penn Medicine Are Testing Vaccines to Prevent Cancer
Researchers across the country are making progress toward vaccines that train healthy people’s immune systems to eliminate signs of cancer before it develops. Healthy BRCA mutation carriers are participating in a clinical trial.
Can We Prevent Cancer With a Shot?
Healthy volunteers who carry BRCA gene mutations are participating in a cancer vaccine clinical trial. If the study is successful, the work could eventually extend to more cancers or other risk factors, noted ACC director Dr. Vonderheide.
The Biology of ‘Precancer’: Stopping Cancer Before It Starts
As Dr. Susan Domchek leads a clinical trial for a cancer interception vaccine, the team seeks to understand “precancer”—the critical period after cells have started to grow abnormally but before they’ve developed into cancer.
Basser Center Board Member and Reporter Discusses Cancer Treatment
Basser executive director Susan Domchek, MD, explains how a class of drugs called PARP inhibitors can help treat cancers related to BRCA mutations to ABC7 news reporter Stacey Sager, who shared an update on her cancer journey.
Big-Time Athletes Swing for a Cure at Mid Penn Bank Celebrity Golf Classic
Money raised from the Mid Penn Bank Celebrity Golf Classic at Hershey Country Club will support cancer research at the Pennsylvania Breast Cancer Coalition and the Basser Center for BRCA at Penn Medicine.
A Shot in the Arm That Can Help Fight Cancer? How Vaccine Trials Are Showing Promise
Filko Prugo, a BRCA2 mutation carrier who is participating in the Basser Center's cancer prevention vaccine trial, shares why clinical trial participation is vital to progress research.
Advancing Cancer Interception
Susan M. Domchek, MD, Basser Center executive director, and Robert H. Vonderheide, MD, DPhil, director of the ACC, report on cancer interception development with rapid advances in technology, therapeutics, and genetic testing methods.
3 Decades, 3 Cancers: Reporter Stacey Sager's Story of Perseverance, Sacrifice and Survival
Stacey Sager shares a series of stories as she takes us through her own courageous and challenging health journey as a BRCA1 gene mutation carrier, featuring Dr. Susan Domchek, the executive director at the Basser Center.
The Basser Center's Race for a Breast Cancer Vaccine
Susan Domchek, MD, executive director of the Basser Center, discusses the latest updates in the race for a cancer prevention vaccine that could benefit individuals and families carrying a BRCA1 or BRCA2 genetic mutation.